2013 Seminars

Jan 15: Targeting the ETS Transcription Factor ESE-1 to Treat Breast Cancer

Arthur Gutierrez-Hartmann, M.D., Professor of Medicine, Department of Medicine and Department of Biochemistry and Molecular Genetics Founding Director, Physician Scientist Program, Internal Medicine Member, Colorado Clinical and Translational Sciences Institute. 
11:00 am-Noon, Nils Hasselmo Hall 2-101

Jan 18: Targeting the Estrogen Receptor for Lung Cancer Therapy and Prevention

Jill M. Siegfried, Ph.D., University of Pittsburgh, School of Medicine; Professor, Department of Pharmacology and Chemical Biology, UPMC Endowed Chair in Lung Cancer Research; Co-Director, Lung and Thoracic Malignancies Program Member, University of Pittsburgh Cancer Institute. 
10:00-11:00 am, Nils Hasselmo Hall 2-101

Nov 6: Regulation of Hypoxia-Inducible Factor 1 in Human Cancer

Weibo Luo, Ph.D.
The John Hopkins Institute for Cell Engineering 
10:00-11:00 am, Nils Hasselmo Hall 2-101

Nov 14: Transcriptional regulation of neurogenesis in the developing and adult brain

Rebecca Hodge, Ph.D.
Acting Instructor
Department of Neurological Surgery, University of Washington
Center for Integrative Brain Research, Seattle Children's Research Institute 
11:00 am- 12:00 pm, Nils Hasselmo Hall 2-101

Dec 4: Targeting the Plasminogen Activation System for Imaging and Therapy in Cancer

Aaron Lebeau, Ph.D.
2013 Steve Wynn Prostate Cancer Foundation Young Investigator
Department of Radiology & Biomedical Imaging, University of California, San Francisco 
10:00-11:00 am, Nils Hasselmo Hall 2-101

Dec 11: Regulation of nicotinic acetylcholine receptors in addiction

Anna Lee, Ph.D.
Research Assistant Professor
Division of Pharmacology and Toxicology, University of Texas at Austin
10:00-11:00 am, Nils Hasselmo Hall 2-101

Dec 18: Alleviation of Alzheimer's Disease-related Plasticity and Memory Deficits by Suppresing PERK-eIF2α

Tao Ma, Ph.D.
Assistant Research Scientist
Center for Neural Science, New York University
10:00-11:00 am, Nils Hasselmo Hall 2-101